Vasculopathy in COVID-19

R Flaumenhaft, K Enjyoji… - Blood, The Journal of the …, 2022 - ashpublications.org
COVID-19 is a primary respiratory illness that is frequently complicated by systemic
involvement of the vasculature. Vascular involvement leads to an array of complications …

[HTML][HTML] From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?

JE Michalski, JS Kurche, DA Schwartz - Translational Research, 2022 - Elsevier
While the coronavirus disease 19 (COVID-19) pandemic has transformed the medical and
scientific communites since it was first reported in late 2019, we are only beginning to …

[HTML][HTML] Differential roles of regulatory T cells in acute respiratory infections

M Jovisic, N Mambetsariev, BD Singer… - The Journal of …, 2023 - Am Soc Clin Investig
JCI - Differential roles of regulatory T cells in acute respiratory infections Go to JCI Insight About
Editors Consulting Editors For authors Publication ethics Alerts Advertising Job board Subscribe …

Clinical characteristics and outcomes of patients with COVID-19–associated acute respiratory distress syndrome who underwent lung transplant

C Kurihara, A Manerikar, M Querrey, C Felicelli… - Jama, 2022 - jamanetwork.com
Importance Lung transplantation is a potentially lifesaving treatment for patients who are
critically ill due to COVID-19–associated acute respiratory distress syndrome (ARDS), but …

[HTML][HTML] Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics

S Dai, C Wang, XT Zhao, C Ma, K Fu, Y Liu… - Pharmacological …, 2023 - Elsevier
Abstract Cucurbitacin B (CuB, C 32 H 46 O 8), the most abundant and active member of
cucurbitacins, which are highly oxidized tetracyclic triterpenoids. Cucurbitacins are widely …

Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the …

G Fiorentino, A Coppola, R Izzo, A Annunziata… - …, 2021 - thelancet.com
Background We and others have previously demonstrated that the endothelium is a primary
target of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and L …

[HTML][HTML] Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection

RJ Mylvaganam, JI Bailey, JI Sznajder… - European respiratory …, 2021 - Eur Respiratory Soc
Acute manifestations of SARS-CoV-2 infection continue to impact the lives of many across
the world. Post-acute sequelae of coronavirus disease 2019 (COVID-19) may affect 10–30 …

Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19

CA Gao, NS Markov, T Stoeger… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND Despite guidelines promoting the prevention and aggressive treatment of
ventilator-associated pneumonia (VAP), the importance of VAP as a driver of outcomes in …

Mechanisms of COVID-19 pathogenesis in diabetes

C Aluganti Narasimhulu… - American Journal of …, 2022 - journals.physiology.org
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in …

Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

D Jonigk, C Werlein, T Acker, M Aepfelbacher… - Virchows Archiv, 2022 - Springer
The use of autopsies in medicine has been declining. The COVID-19 pandemic has
documented and rejuvenated the importance of autopsies as a tool of modern medicine. In …